New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability

Tekijä Gumbo, Tawanda
Julkaistu 2010

An Empirical Study of the Relationship between Money Market Interest Rates and Stock Market Performance: Evidence from Zimbabwe (2009-2013)

Tekijä Trust Kganyago, Victor Gumbo
Julkaistu 2015-09-01

Anidulafungin in the treatment of invasive fungal infections

Tekijä Sabol, Kathryn, Gumbo, Tawanda
Julkaistu 2008

An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future

Tekijä Pasipanodya, Jotam, Gumbo, Tawanda
Julkaistu 2011

Reply to “Pharmacokinetic Mismatch of Tuberculosis Drugs”

Tekijä Srivastava, Shashikant, Gumbo, Tawanda
Julkaistu 2012

Africanising the Curriculum

Tekijä Msilaÿ, Vuyisile, Gumbo, Mishack T
Julkaistu 2016

Reply to Zimenkov, “Mutation in luxR Family Transcriptional Regulator Rv0890c Is Not a Marker of Linezolid Resistance”

Tekijä Srivastava, Shashikant, Gumbo, Tawanda
Julkaisussa Antimicrob Agents Chemother (2018)

Clofazimine for the Treatment of Mycobacterium kansasii

Tekijä Srivastava, Shashikant, Gumbo, Tawanda
Julkaisussa Antimicrob Agents Chemother (2018)

Clinical and Toxicodynamic Evidence that High-Dose Pyrazinamide Is Not More Hepatotoxic than the Low Doses Currently Used

Tekijä Pasipanodya, Jotam G., Gumbo, Tawanda
Julkaistu 2010

A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs

Tekijä Pasipanodya, Jotam G., Gumbo, Tawanda
Julkaistu 2011

A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients

Tekijä Pasipanodya, Jotam G., Gumbo, Tawanda
Julkaistu 2013

Reply to Moonan and Weis, Seaworth et al, and Nunn and Phillips

Tekijä Pasipanodya, Jotam G., Gumbo, Tawanda
Julkaistu 2013

A LAND SUITABILITY ANALYSIS OF THE VHEMBE DISTRICT, SOUTH AFRICA, THE CASE OF MAIZE AND SORGHUM

Tekijä A. A. Mufungizi, W. Musakwa, T. Gumbo
Julkaistu 2020-08-01

New Susceptibility Breakpoints and the Regional Variability of MIC Distribution in Mycobacterium tuberculosis Isolates

Tekijä Pasipanodya, Jotam, Srivastava, Shashikant, Gumbo, Tawanda
Julkaistu 2012

Knowledge, Attitude and Practices (KAP) Survey on Water, Sanitation and Hygiene in Selected Schools in Vhembe District, Limpopo, South Africa

Tekijä Sibiya, Jerry E., Gumbo, Jabulani Ray
Julkaistu 2013

Assessment of Heavy Metals in Municipal Sewage Sludge: A Case Study of Limpopo Province, South Africa

Tekijä Shamuyarira, Kudakwashe K., Gumbo, Jabulani R.
Julkaistu 2014

Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance

Tekijä Srivastava, Shashikant, Deshpande, Devyani, Gumbo, Tawanda
Julkaisussa J Antimicrob Chemother (2017)

Pharmacokinetic/Pharmacodynamic Background and Methods and Scientific Evidence Base for Dosing of Second-line Tuberculosis Drugs

Tekijä Gumbo, Tawanda, Alffenaar, Jan-Willem C
Julkaisussa Clin Infect Dis (2018)

Assessment of impact of land use change on the wetland in Makhitha village, Limpopo province, South Africa

Tekijä Phethi, Mpho D., Gumbo, Jabulani R.
Julkaisussa Jamba (2019)

Effect of specimen processing, growth supplement, and different metabolic population on Mycobacterium tuberculosis laboratory diagnosis

Tekijä Srivastava, Shashikant, Chapagain, Moti, Gumbo, Tawanda
Julkaisussa PLoS One (2020)